Focused Ultrasound Surgery in Gynecology (PDF)

working to develop HIFU (high-intensity focused ultrasound) system. He was in charge of (or participated in) multiple scientific research projects. He was awarded multiple city-level and national-level scientific awards.



Over the last 10 years, he was at CIRSE, WCIO, SIUMB, PARIS, and among others, as an invited speaker. Prof. Lian Zhang's research areas and interests extend to anatomy, molecular biology, molecular genealogy, oncology, etc. He has published more than 80 papers in the peered review journals such as Acta Obstet Gynecol Scand., BJOG., Int J Gynaecol Obstet. Circulation, Journal of Clinical Investigation, Radiology, European Radiology, European Journal of Radiology, American Journal of Roentgenology, Ultrasounics Sonochemistry, International Journal of Hyperthermia and Medicine.



He is now responsible for training HIFU surgeons or physicians worldwide. He is currently the Secretary General of the International Society of Minimally Invasive and Virtual Surgery, the Secretary General of the Minimally Invasive and Noninvasive Medical Committee of Chinese Medical Doctor Association. He serves as a section editor of the International Journal of Hyperthermia.



Professor Zhibiao WANG, MD/Ph.D, Professor of ObGyn and Biomedical Engineering, Ph.D. student supervisor, Senior Consultant of ObGyn, Chongqing Medical University; Director of the National Engineering Research Center of Ultrasound Medicine (NERCUM) and the State Key Laboratory of Ultrasound in Medicine and Engineering, respectively; Council member of the International Society of Minimally Invasive and Virtual Surgery (ISMIVS). Professor Wang is the Principal Investigator of the research grant awarded by the National Key Basic Research and Development Program (973 Program) in 2010 and the special fund for the Development of major Scientific Research Equipment awarded by the National Natural Science Foundation of China. He was the recipient of the National Science Fund for Distinguished Young Scholars, the second prize of the State Technological Invention Award in 2000, the HLHL (HO LEUNG HO LEE) Advancement Prize in 2008, the second prize of the National Science and Technology Progress Award in 2010, and the National Innovation Award in 2020.



Prof. Wang has devoted for decades to the development and clinical implementation of minimally invasive and non-invasive treatment of common gynecological diseases, such as uterine fibroids, adenomyosis, cervicitis, non-neoplastic epithelial disorders of the vulva, etc.



Since 1988, adhering to the medical philosophy of "Treatment-minimize harm to patients", Professor Wang has a long track record of innovative and original research on the theoretic framework of therapeutic ultrasound, its clinical translation, and clinical development of focused ultrasound therapies. He proposed for the very first time the concept of "Biological Focal Region", laying the theoretic foundation for clinical application of focused ultrasound ablative therapy. His team successfully developed the world-first High Intensity Focused Ultrasound Tumor Therapeutic System, the JC series with independent intellectual property rights. It led the clinical development and global deployment of HIFU technology, realizing the medical dream of non-invasive extracorporeal treatment of the lesions within the body. At present, a series of ultrasound therapy devices developed by Prof. Wang's team is being used by more than 2,800 hospitals worldwide, having treated more than 150,000 patients with benign and malignant diseases, such as uterine fibroids, liver cancer, breast cancer, and osteosarcoma, etc., and more than 2 million patients with non-tumor diseases.